GeneXpert MTB/XDR is a rapid molecular test that detects Mycobacterium tuberculosis (MTB) DNA in a clinical sample and identifies resistance to key anti-tuberculosis drugs, including isoniazid, fluoroquinolones, and second-line injectable drugs. It is needed to support the rapid diagnosis of tuberculosis and detect drug-resistant TB, helping clinicians select appropriate treatment promptly and reduce the risk of treatment failure and disease transmission.
XDR refers to extensively drug-resistant tuberculosis. The test detects resistance-associated mutations to multiple important anti-TB drugs.
Depending on the assay, GeneXpert MTB/XDR detects resistance markers for isoniazid, fluoroquinolones, and certain second-line injectable drugs, along with MTB detection.
Detection of MTB supports tuberculosis infection, but the result should be interpreted along with symptoms, imaging, examination, and other laboratory findings.
No. A negative result does not always exclude TB, particularly when the bacterial load is low or the sample is inadequate.
Certainly. It detects specific genetic mutations associated with resistance to several anti-TB drugs.
No. GeneXpert MTB/XDR detects MTB genetic material and drug-resistance markers but does not by itself distinguish latent TB infection from active TB disease.